{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:54:37Z","timestamp":1781333677983,"version":"3.54.1"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH U01 CA227954"],"award-info":[{"award-number":["NIH U01 CA227954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH U19 CA264362"],"award-info":[{"award-number":["NIH U19 CA264362"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001512","name":"National Brain Tumor Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012764","name":"William H. Donner Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ataxia Telangiectasia\u2013mutated (ATM) inhibitors are being developed as radiosensitizers to improve the antitumor effects of radiotherapy, but ATM inhibition can also radiosensitize normal tissues. Therefore, understanding the elevated risk of normal tissue toxicities is critical for radiosensitizer development. This study focused on modeling the relationship between acute mucosal toxicity, radiation dose, fractionation schedule, and radiosensitizer exposure. The ATM inhibitor WSD0628 was combined with single or fractionated doses of radiation delivered to the oral cavity or esophagus of Friend Leukemia virus B (FVB) mice. The potentiation by WSD0628 was quantified by a sensitizer enhancement ratio (SER), which describes the changes in radiation tolerance for radiation combined with WSD0628 relative to radiation-only regimens. WSD0628 profoundly enhanced radiation-induced acute oral and esophageal toxicities. For oral mucosal toxicity, the enhancement by WSD0628 with 3 fractions of radiation resulted in an SER ranging from 1.3 (0.25 mg\/kg) to 3.1 (7.5 mg\/kg). For the 7.5 mg\/kg combination, the SER increased with increasing number of fractions from 2.2 (1 fraction) to 4.3 (7 fractions) for oral toxicity and from 2.2 (1 fraction) to 3.6 (3 fractions) for esophageal toxicity, which reflects a loss of the normal tissue sparing benefit of fractionated radiation. These findings were used to develop a modified biologically effective dose model to determine alternative radiation schedules with or without WSD0628 that result in similar levels of toxicity. Successful radiosensitizer dose escalation to a maximally effective therapeutic dose will require careful deliberation of tumor site and reduction of radiation dose volume limits for organs at risk.<\/jats:p>","DOI":"10.1158\/1535-7163.mct-24-0664","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T04:34:40Z","timestamp":1731990880000},"page":"299-309","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628"],"prefix":"10.1158","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4656-3401","authenticated-orcid":false,"given":"Darwin A.","family":"Garcia","sequence":"first","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4631-0085","authenticated-orcid":false,"given":"Sneha","family":"Rathi","sequence":"additional","affiliation":[{"name":"2Department of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0094-0030","authenticated-orcid":false,"given":"Margaret A.","family":"Connors","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-6926","authenticated-orcid":false,"given":"Michael","family":"Grams","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-5975","authenticated-orcid":false,"given":"Rachael A.","family":"Vaubel","sequence":"additional","affiliation":[{"name":"3Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8900-0077","authenticated-orcid":false,"given":"Katrina K.","family":"Bakken","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9109-317X","authenticated-orcid":false,"given":"Lauren L.","family":"Ott","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2460-3079","authenticated-orcid":false,"given":"Brett L.","family":"Carlson","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1781-5812","authenticated-orcid":false,"given":"Zeng","family":"Hu","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-4227","authenticated-orcid":false,"given":"Paul A.","family":"Decker","sequence":"additional","affiliation":[{"name":"4Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-1114","authenticated-orcid":false,"given":"Jeanette E.","family":"Eckel-Passow","sequence":"additional","affiliation":[{"name":"4Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-5579","authenticated-orcid":false,"given":"Danielle M.","family":"Burgenske","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2917-4832","authenticated-orcid":false,"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[{"name":"5Wayshine Biopharm, Corona, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-5449","authenticated-orcid":false,"given":"Joshua D.","family":"Trzasko","sequence":"additional","affiliation":[{"name":"6Department of Radiology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9655-2338","authenticated-orcid":false,"given":"Michael G.","family":"Herman","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-3429","authenticated-orcid":false,"given":"William F.","family":"Elmquist","sequence":"additional","affiliation":[{"name":"2Department of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8672-3231","authenticated-orcid":false,"given":"Nicholas B.","family":"Remmes","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7489-4885","authenticated-orcid":false,"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2025020408075371400_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2021.09.008","article-title":"Targeting the ATM kinase to enhance the efficacy of radiotherapy and outcomes for cancer patients","volume":"32","author":"Garc\u00eda","year":"2022","journal-title":"Semin Radiat Oncol"},{"key":"2025020408075371400_bib2","doi-asserted-by":"crossref","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci Adv"},{"key":"2025020408075371400_bib3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1535-7163.MCT-21-0934","article-title":"A new class of selective ATM inhibitors as combination partners of DNA double-strand break inducing cancer therapies","volume":"21","author":"Zimmermann","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"2025020408075371400_bib4","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation","volume":"19","author":"Biddlestone-Thorpe","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2025020408075371400_bib5","doi-asserted-by":"crossref","first-page":"eadj5962","DOI":"10.1126\/scitranslmed.adj5962","article-title":"Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization","volume":"16","author":"Chen","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025020408075371400_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","article-title":"Clinical radiation sensitivity with DNA repair disorders: an overview","volume":"74","author":"Pollard","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","article-title":"Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis","volume":"114","author":"Gotoff","year":"1967","journal-title":"Am J Dis Child"},{"key":"2025020408075371400_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"2025020408075371400_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0146645314560686","article-title":"Radiobiology of tissue reactions","volume":"44","author":"D\u00f6rr","year":"2015","journal-title":"Ann ICRP"},{"key":"2025020408075371400_bib10","volume-title":"Inventor; Substituted 1-(3,3-difluoropiperidin-4-yl)-imidazo[4,5-c] quinolin-2-one compounds with blood-brain barrier penetrable capability","author":"Zhong","year":"2022"},{"key":"2025020408075371400_bib11","doi-asserted-by":"crossref","first-page":"20180487","DOI":"10.1259\/bjr.20180487","article-title":"Quantifying the setup uncertainty of a stereotactic murine micro-image guided radiation therapy system","volume":"92","author":"Walb","year":"2019","journal-title":"Br J Radiol"},{"key":"2025020408075371400_bib12","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.ijrobp.2021.08.003","article-title":"Preclinical risk evaluation of normal tissue injury with novel radiosensitizers","volume":"111","author":"Dragojevic","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib13","doi-asserted-by":"crossref","first-page":"e0233562","DOI":"10.1371\/journal.pone.0233562","article-title":"Methodology for radiochromic film analysis using FilmQA Pro and ImageJ","volume":"15","author":"Howard","year":"2020","journal-title":"PLoS One"},{"key":"2025020408075371400_bib14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/09553002.2014.922719","article-title":"Design and characterization of an economical (192)Ir hemi-brain small animal irradiator","volume":"90","author":"Grams","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"2025020408075371400_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.123.001971","article-title":"Preclinical systemic pharmacokinetics, dose proportionality, and central nervous system distribution of the ATM inhibitor WSD0628, a novel radiosensitizer for the treatment of brain tumors","volume":"390","author":"Rathi","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"2025020408075371400_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/09553008514553221","article-title":"Direct analysis of quantal radiation response data","volume":"49","author":"Thames","year":"1986","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"2025020408075371400_bib17","doi-asserted-by":"crossref","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"2025020408075371400_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ijrobp.2022.10.012","article-title":"Manipulation of redox metabolism using pharmacologic ascorbate opens a therapeutic window for radio-sensitization by ATM inhibitors in colorectal cancer","volume":"115","author":"Callaghan","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.nano.2017.03.002","article-title":"Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy","volume":"13","author":"Caster","year":"2017","journal-title":"Nanomedicine"},{"key":"2025020408075371400_bib20","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1039\/C5NR05869D","article-title":"Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery","volume":"7","author":"Tian","year":"2015","journal-title":"Nanoscale"},{"key":"2025020408075371400_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ijrobp.2018.11.063","article-title":"Beware of clinical trials of DNA repair inhibitors","volume":"103","author":"Brown","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jnci\/djs472","article-title":"NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers","volume":"105","author":"Lawrence","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2025020408075371400_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0360-3016(90)90538-U","article-title":"Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa","volume":"19","author":"Van der Schueren","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cncr.28515","article-title":"Stereotactic body radiotherapy: a critical review for nonradiation oncologists","volume":"120","author":"Kirkpatrick","year":"2014","journal-title":"Cancer"},{"key":"2025020408075371400_bib25","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"2025020408075371400_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2023.09.024","article-title":"A phase 1 study of the DNA-PK inhibitor peposertib in combination with radiation therapy with or without cisplatin in patients with advanced head and neck tumors","volume":"118","author":"Samuels","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","article-title":"Atm-deficient mice: a paradigm of ataxia telangiectasia","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"key":"2025020408075371400_bib28","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1073\/pnas.97.4.1584","article-title":"The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest","volume":"97","author":"Wang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025020408075371400_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","article-title":"Cellular functions of the protein kinase ATM and their relevance to human disease","volume":"22","author":"Lee","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025020408075371400_bib30","doi-asserted-by":"crossref","first-page":"e10001","DOI":"10.1371\/journal.pone.0010001","article-title":"Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants","volume":"5","author":"Adams","year":"2010","journal-title":"PLoS One"},{"key":"2025020408075371400_bib31","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion","volume":"8","author":"Golding","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2025020408075371400_bib32","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers14153794","article-title":"DNA repair inhibitors potentiate fractionated radiotherapy more than single-dose radiotherapy in breast cancer cells","volume":"14","author":"Wong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025020408075371400_bib33","doi-asserted-by":"crossref","first-page":"01TR","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys Med Biol"},{"key":"2025020408075371400_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(82)90517-X","article-title":"Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships","volume":"8","author":"Thames","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025020408075371400_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-8140(93)90042-7","article-title":"Capacity and kinetics of SLD repair in mouse tongue epithelium","volume":"27","author":"D\u00f6rr","year":"1993","journal-title":"Radiother Oncol"},{"issue":"Suppl 9","key":"2025020408075371400_bib36","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"2025020408075371400_bib37","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.280.5366.1089","article-title":"Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system","volume":"280","author":"Herzog","year":"1998","journal-title":"Science"}],"container-title":["Molecular Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/doi\/10.1158\/1535-7163.MCT-24-0664\/3518913\/mct-24-0664.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/doi\/10.1158\/1535-7163.MCT-24-0664\/3524615\/mct-24-0664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/24\/2\/299\/3537452\/mct-24-0664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/24\/2\/299\/3537452\/mct-24-0664.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:08:56Z","timestamp":1738638536000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mct\/article\/24\/2\/299\/751275\/Modeling-the-Acute-Mucosal-Toxicity-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,19]]},"published-print":{"date-parts":[[2025,2,4]]}},"URL":"https:\/\/doi.org\/10.1158\/1535-7163.mct-24-0664","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1535-7163.28342309","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.28342318","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.28342327","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.28342306","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.28342312","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.28342321","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1535-7163.c.7657006","asserted-by":"object"}]},"ISSN":["1535-7163","1538-8514"],"issn-type":[{"value":"1535-7163","type":"print"},{"value":"1538-8514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}